Correction: Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry

被引:0
|
作者
Wern Yew Ding
Ameenathul Mazaya Fawzy
Giulio Francesco Romiti
Marco Proietti
Daniele Pastori
Menno V. Huisman
Gregory Y. H. Lip
Ameenathul Mazaya Fawzy
机构
[1] University of Liverpool,Liverpool Centre for Cardiovascular Science
[2] Liverpool John Moores University and Liverpool Heart & Chest Hospital,Department of Translational and Precision Medicine
[3] Sapienza - University of Rome,Division of Subacute Care
[4] IRCCS Istituti Clinici Scientifici Maugeri,Department of Clinical Sciences and Community Health
[5] University of Milan,Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences
[6] Sapienza University of Rome,Department of Thrombosis and Hemostasis
[7] Leiden University Medical Center,Department of Clinical Medicine, Aalborg Thrombosis Research Unit
[8] Aalborg University,undefined
关键词
D O I
10.1007/s11239-023-02904-9
中图分类号
学科分类号
摘要
引用
收藏
页码:178 / 178
相关论文
共 50 条
  • [21] Impact of chronic obstructive pulmonary disease on the natural history of atrial fibrillation: a report from the GLORIA-AF registry phase II & III
    Romiti, G. F.
    Proietti, M.
    Corica, B.
    Mei, D. A.
    Frost, F.
    Bisson, A.
    Boriani, G.
    Olshansky, B.
    Chao, T. F.
    Huisman, M. V.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [22] Characteristics of Patients With Asymptomatic Atrial Fibrillation and Ischemic Stroke-Insights From the GLORIA-AF Registry (Phase 2)
    Heer, Tobias
    Zeymer, Uwe
    Schwarzbach, Christopher J.
    Seidl, Karlheinz
    Rauch-Kroehnert, Ursula
    Marler, Sabrina
    Teutsch, Christine
    Diener, Hans-Christoph
    Senges, Jochen
    Lip, Gregory Y. H.
    Huisman, Menno V.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2025, 48 (01): : 42 - 49
  • [23] A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics
    Huisman, M. V.
    Diener, H. -C.
    Dubner, S. J.
    Halperin, J. L.
    Rothman, K. J.
    Ma, C. -S.
    Lu, S.
    Paquette, M.
    Teutsch, C.
    Franca, L. R.
    Zint, K.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 825 - 825
  • [24] Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation
    Rivera-Caravaca, Jose Miguel
    Teruel-Montoya, Raul
    Roldan, Vanessa
    Cifuentes-Riquelme, Rosa
    Crespo-Matas, Jose Antonio
    de los Reyes-garcia, Ascension Maria
    Aguila, Sonia
    Fernandez-Perez, Maria Piedad
    Reguilon-Gallego, Laura
    Zapata-Martinez, Laura
    Garcia-Barbera, Nuria
    Vicente, Vicente
    Marin, Francisco
    Martinez, Constantino
    Gonzalez-Conejero, Rocio
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 11
  • [25] Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry
    Ntaios, George
    Huisman, Menno, V
    Diener, Hans-Christoph
    Halperin, Jonathan L.
    Teutsch, Christine
    Marler, Sabrina
    Gurusamy, Venkatesh K.
    Thompson, Milla
    Lip, Gregory Y. H.
    Olshansky, Brian
    HELLENIC JOURNAL OF CARDIOLOGY, 2021, 62 (02) : 152 - 157
  • [26] Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry
    Bayer, Valentina
    Kotalczyk, Agnieszka
    Kea, Bory
    Teutsch, Christine
    Larsen, Peter
    Button, Dana
    Huisman, Menno, V
    Lip, Gregory Y. H.
    Olshansky, Brian
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (06):
  • [27] Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry
    Lam, Steven Ho Man
    Romiti, Giulio Francesco
    Olshansky, Brian
    Chao, Tze-Fan
    Huisman, Menno V.
    Lip, Gregory Yoke Hong
    INTERNAL AND EMERGENCY MEDICINE, 2024, 19 (05) : 1369 - 1378
  • [28] Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry Program
    Ma, Changsheng
    Kim, Young Hoon
    Higashino, Yorihiko
    Shlyakhto, Evgeny V.
    Dubner, Sergio J.
    Halperin, Jonathan L.
    Rothman, Kenneth J.
    Lu, Shihai
    Franca, Lionel Riou
    Paquette, Miney
    Teutsch, Christine
    Huisman, Menno V.
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C175 - C176
  • [29] Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior Stroke in GLORIA-AF Phase II (Global Registry on Long-term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation, Phase II).
    Diener, Hans-Christoph
    Huisman, Menno, V
    Halperin, Jonathan L.
    Dubner, Sergio J.
    Ma, Chang S.
    Rothman, Kenneth J.
    Zint, Kristina
    Elsaesser, Amelie
    Paquette, Miney
    Teutsch, Christine
    Bartels, Dorothee
    STROKE, 2016, 47
  • [30] Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry
    Menno V. Huisman
    Christine Teutsch
    Shihai Lu
    Hans-Christoph Diener
    Sergio J. Dubner
    Jonathan L. Halperin
    Chang-Sheng Ma
    Kenneth J. Rothman
    Ragna Lohmann
    Venkatesh Kumar Gurusamy
    Dorothee B. Bartels
    Gregory Y. H. Lip
    Clinical Research in Cardiology, 2022, 111 : 548 - 559